Kyntra Bio (KYNB)

• Market cap: $32.8M
• 1 day: 8.27%
• 5 days: 3.84%
• 1 month: -9.98%
• 3 months: -26.18%
• 6 months: 14.21%
• Year to date: -11.35%
• 1 year: -35.04%
• 5 years: -99.39%
• 10 years: -97.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 225